Truncated tau deregulates synaptic markers in rat model for human tauopathy

Frontiers in Cellular Neuroscience

Volumn 9, Issue FEB, 2015, Pages

  Jadhav, Santosh ^a   Katina, Stanislav ^b,c   Kovac, Andrej ^b   Kazmerova, Zuzana ^a   Novak, Michal ^a,b   Zilka, Norbert ^a,b  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^b Axon Neuroscience GmbH   (Slovakia)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Alzheimer s disease; Phosphorylation; Synaptic damage; Tau mislocalization; Truncated tau

Indexed keywords

ALPHA TUBULIN; AMYLOID BETA PROTEIN [1-40]; AMYLOID BETA PROTEIN [1-42]; BETA TUBULIN; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT H PROTEIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN; TAU PROTEIN; TRUNCATED TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONFOCAL LASER MICROSCOPY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTIONATION; IMMUNOREACTIVITY; MALE; MICROTUBULE; NEUROFILAMENT; NONHUMAN; POSTSYNAPTIC DENSITY; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; SYNAPSE VESICLE; SYNAPTIC POTENTIAL; SYNAPTOSOME; TAUOPATHY; TRANSGENIC RAT; WESTERN BLOTTING;

EID: 84923225427     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00024     Document Type: Article

References (83)

1. Andorfer, C., Kress, Y., Espinoza, M., de Silva, R., Tucker, K. L., Barde, Y. A., et al. (2003). Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 86, 582-590. doi: 10.1046/j.1471-4159.2003.01879.x.
2. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., and Hyman, B. T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42, 631-639. doi: 10.1212/wnl.42.3.631.
3. Augustinack, J. C., Schneider, A., Mandelkow, E. M., and Hyman, B. T. (2002). Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease. Acta Neuropathol. 103, 26-35. doi: 10.1007/s004010100423.
4. Bajo, M., Yoo, B. C., Cairns, N., Gratzer, M., and Lubec, G. (2001). Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer’s disease. Amino Acids 21, 293-301. doi: 10.1007/s007260170015.
5. Bigio, E. H., Vono, M. B., Satumtira, S., Adamson, J., Sontag, E., Hynan, L. S., et al. (2001). Cortical synapse loss in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 60, 403-410.
6. Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., and Teplow, D. B. (2003). Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U S A 100, 330-335. doi: 10.1073/pnas.222681699.
7. Blennow, K., Bogdanovic, N., Alafuzoff, I., Ekman, R., and Davidsson, P. (1996). Synaptic pathology in Alzheimer’s disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J. Neural Transm. 103, 603-618. doi: 10.1007/bf01273157.
8. Blomberg, F., Cohen, R. S., and Siekevitz, P. (1977). The structure of postsynaptic densities isolated from dog cerebral cortex. II. Characterization and arrangement of some of the major proteins within the structure. J. Cell Biol. 74, 204-225. doi: 10.1083/jcb.74.1.204.
9. Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259. doi: 10.1007/bf00308809.
10. Brun, A., Liu, X., and Erikson, C. (1995). Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer’s disease and in frontal lobe degeneration. Neurodegeneration 4, 171-177. doi: 10.1006/neur.1995.0021.
11. Callahan, L. M., and Coleman, P. D. (1995). Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer’s disease. Neurobiol. Aging 16, 311-314. doi: 10.1016/0197-4580(95)00035-d.
12. Callahan, L. M., Selski, D. J., Martzen, M. R., Cheetham, J. E., and Coleman, P. D. (1994). Preliminary evidence: decreased GAP-43 message in tangle-bearing neurons relative to adjacent tangle-free neurons in Alzheimer’s disease parahippocampal gyrus. Neurobiol. Aging 15, 381-386. doi: 10.1016/0197-4580(94)90041-8.
13. Callahan, L. M., Vaules, W. A., and Coleman, P. D. (2002). Progressive reduction of synaptophysin message in single neurons in Alzheimer disease. J. Neuropathol. Exp. Neurol. 61, 384-395.
14. Ciani, L., Boyle, K. A., Dickins, E., Sahores, M., Anane, D., Lopes, D. M., et al. (2011). Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca2+/Calmodulin-dependent protein kinase II. Proc. Natl. Acad. Sci. USA108,10732-10737.doi:10.1073/pnas.1018132108.
15. Cohen, R. S., Blomberg, F., Berzins, K., and Siekevitz, P. (1977). The structure of postsynaptic densities isolated from dog cerebral cortex. I. Overall morphology and protein composition. J. Cell Biol. 74, 181-203. doi: 10.1083/jcb.74.1.181.
16. Coleman, P. D., Kazee, A. M., Lapham, L., Eskin, T., and Rogers, K. (1992). Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer’s disease. Neurobiol. Aging 13, 631-639. doi: 10.1016/0197-4580(92)90085-c.
17. Coleman, P. D., and Yao, P. J. (2003). Synaptic slaughter in Alzheimer’s disease. Neurobiol. Aging 24, 1023-1027. doi: 10.1016/j.neurobiolaging.2003.09.001.
18. Counts, S. E., Nadeem, M., Lad, S. P., Wuu, J., and Mufson, E. J. (2006). Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J. Neuropathol. Exp. Neurol. 65, 592- 601. doi: 10.1097/00005072-200606000-00007.
19. Cras, P., Kawai, M., Lowery, D., Gonzalez-DeWhitt, P., Greenberg, B., and Perry, G. (1991). Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc. Natl. Acad. Sci. U S A 88, 7552-7556. doi: 10.1073/pnas.88.17.7552.
20. Davies, C. A., Mann, D. M., Sumpter, P. Q., and Yates, P. O. (1987). A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease. J. Neurol. Sci. 78, 151-164. doi: 10.1016/0022-510x(87)90057-8.
21. DeKosky, S. T., and Scheff, S. W. (1990). Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann. Neurol. 27, 457-464. doi: 10.1002/ana.410270502.
22. Efron, B., and Tibshirani, R. J. (1993). An Introduction to the Bootstrap. 1st Edn. New York: Chapman and Hall.
23. Falke, E., Nissanov, J., Mitchell, T. W., Bennett, D. A., Trojanowski, J. Q., and Arnold, S. E. (2003). Subicular dendritic arborization in Alzheimer’s disease correlates with neurofibrillary tangle density. Am. J. Pathol. 163, 1615-1621. doi: 10.1016/s0002-9440(10)63518-3.
24. Fein, J. A., Sokolow, S., Miller, C. A., Vinters, H. V., Yang, F., Cole, G. M., et al. (2008). Co-localization of amyloid beta and tau pathology in Alzheimer’s disease synaptosomes. Am. J. Pathol. 172, 1683-1692. doi: 10.2353/ajpath.2008.070829.
25. Filipcik, P., Zilka, N., Bugos, O., Kucerak, J., Koson, P., Novak, P., et al. (2012). First transgenic rat model developing progressive cortical neurofibrillary tangles. Neurobiol. Aging 33, 1448-1456. doi: 10.1016/j.neurobiolaging.2010.10.015.
26. Fischer, D., Mukrasch, M. D., Biernat, J., Bibow, S., Blackledge, M., Griesinger, C., et al. (2009). Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules. Biochemistry 48, 10047-10055. doi: 10.1021/bi901090m.
27. Greenberg, S. G., and Davies, P. (1990). A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. U S A 87, 5827-5831. doi: 10.1073/pnas.87.15.5827.
28. Hahn, C. G., Banerjee, A., Macdonald, M. L., Cho, D. S., Kamins, J., Nie, Z., et al. (2009). The postsynaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnesses. PLoS One 4:e5251. doi: 10.1371/journal.pone.0005251.
29. Hammond, J., Cai, D., and Verhey, K. J. (2008). Tubulin modifications and their cellular functions. Curr. Opin. Cell Biol. 20, 71-76. doi: 10.1016/j.ceb.2007.11.010.
30. Hanes, J., Zilka, N., Bartkova, M., Caletkova, M., Dobrota, D., and Novak, M. (2009). Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies. J. Neurochem. 108, 1167-1176. doi: 10.1111/j.1471-4159.2009.05869.x.
31. Heffernan, J. M., Eastwood, S. L., Nagy, Z., Sanders, M. W., McDonald, B., and Harrison, P. J. (1998). Temporal cortex synaptophysin mRNA is reduced in Alzheimer’s disease and is negatively correlated with the severity of dementia. Exp. Neurol. 150, 235-239. doi: 10.1006/exnr.1997.6772.
32. Honer, W. G. (2003). Pathology of presynaptic proteins in Alzheimer’s disease: more than simple loss of terminals. Neurobiol. Aging 24, 1047-1062. doi: 10.1016/j.neurobiolaging.2003.04.005.
33. Honer, W. G., Dickson, D. W., Gleeson, J., and Davies, P. (1992). Regional synaptic pathology in Alzheimer’s disease. Neurobiol. Aging 13, 375-382. doi: 10.1016/0197-4580(92)90111-a.
34. Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley-Whyte, E. T., Frosch, M. P., et al. (2004). Early Abeta accumulation and progressive synaptic loss, gliosis and tangle formation in AD brain. Neurology 62, 925-931. doi: 10.1212/01.wnl.0000115115.98960.37.
35. Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., et al. (2010). Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 142, 387-397. doi: 10.1016/j.cell.2010.06.036.
36. Ivanov, A., Esclapez, M., and Ferhat, L. (2009). Role of drebrin A in dendritic spine plasticity and synaptic function. Implications in neurological disorders. Commun. Integr. Biol. 2, 268-270. doi: 10.4161/cib.2.3.8166.
37. Jan, A., Gokce, O., Luthi-Carter, R., and Lashuel, H. A. (2008). The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloidbeta aggregation, fibrillogenesis and toxicity. J. Biol. Chem. 283, 28176-28189. doi: 10.1074/jbc.m803159200.
38. Kambe, T., Motoi, Y., Inoue, R., Kojima, N., Tada, N., Kimura, T., et al. (2011). Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice. Neurobiol. Dis. 42, 404-414. doi: 10.1016/j.nbd.2011.02.002.
39. Kanai, Y., and Hirokawa, N. (1995). Sorting mechanisms of tau and MAP2 in neurons: suppressed axonal transit of MAP2 and locally regulated microtubule binding. Neuron 14, 421-432. doi: 10.1016/0896-6273(95)90298-8.
40. Khatoon, S., Grundke-Iqbal, I., and Iqbal, K. (1994). Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett. 351, 80-84. doi: 10.1016/0014-5793(94)00829-9.
41. Kittur, S., Hoh, J., Endo, H., Tourtellotte, W., Weeks, B. S., Markesbery, W., et al. (1994). Cytoskeletal neurofilament gene expression in brain tissue from Alzheimer’s disease patients. I. Decrease in NF-L and NF-M message. J. Geriatr. Psychiatry Neurol. 7, 153-158. doi: 10.1177/089198879400700305.
42. Kontsekova, E., Zilka, N., Kovacech, B., Skrabana, R., and Novak, M. (2014). Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease. Alzheimers Res. Ther. 6:45. doi: 10.1186/alzrt277.
43. Koson, P., Zilka, N., Kovac, A., Kovacech, B., Korenova, M., Filipcik, P., et al. (2008). Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. Eur. J. Neurosci. 28, 239-246. doi: 10.1111/j.1460-9568.2008.06329.x.
44. Lee, G., and Rook, S. L. (1992). Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J. Cell Sci. 102, 227-237.
45. Liu, S. H., Cheng, H. H., Huang, S. Y., Yiu, P. C., and Chang, Y. C. (2006). Studying the protein organization of the postsynaptic density by a novel solid phase- and chemical cross-linking-based technology. Mol. Cell. Proteomics 5, 1019-1032. doi: 10.1074/mcp.m500299-mcp200.
46. Marcos, S., Moreau, J., Backer, S., Job, D., Andrieux, A., and Bloch-Gallego, E. (2009). Tubulin tyrosination is required for the proper organization and pathfinding of the growth cone. PLoS One 4:e5405. doi: 10.1371/journal.pone.0005405.
47. Masliah, E., Ellisman, M., Carragher, B., Mallory, M., Young, S., Hansen, L., et al. (1992). Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease. J. Neuropathol. Exp. Neurol. 51, 404-414. doi: 10.1097/00005072-199207000-00003.
48. Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W. Jr., et al. (2001). Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease. Neurology 56, 127-129. doi: 10.1212/wnl.56.1.127.
49. Matsuzaki, K. (2011). Formation of toxic amyloid fibrils by amyloid β-protein on ganglioside clusters. Int. J. Alzheimers Dis. 2011:956104. doi: 10.4061/2011/956104.
50. Mocanu, M. M., Nissen, A., Eckermann, K., Khlistunova, I., Biernat, J., Drexler, D., et al. (2008). The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 28, 737-748. doi: 10.1523/jneurosci.2824-07.2008.
51. Mondragón-Rodríguez, S., Trillaud-Doppia, E., Dudilot, A., Bourgeois, C., Lauzon, M., Leclerc, N., et al. (2012). Interaction of endogenous tau protein with synaptic proteins is regulated by N-Methyl-D-aspartate receptor-dependent tau phosphorylation. J. Biol. Chem. 287, 32040-32053. doi: 10.1074/jbc.m112.401240.
52. Moreno, H., Yu, E., Pigino, G., Hernandez, A. I., Kim, N., Moreira, J. E., et al. (2009). Synaptic transmission block by presynaptic injection of oligomeric amyloid beta. Proc. Natl. Acad. Sci. U S A 106, 5901-5906. doi: 10.1073/pnas.0900944106.
53. Papasozomenos, S. C., and Su, Y. (1991). Altered phosphorylation of tau protein in heat-shocked rats and patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA88,4543-4547.doi:10.1073/pnas.88.10.4543.
54. Paturle, L., Wehland, J., Margolis, R. L., and Job, D. (1989). Complete separation of tyrosinated, detyrosinated and nontyrosinatable brain tubulin subpopulations using affinity chromatography. Biochemistry 28, 2698-2704. doi: 10.1021/bi00432a050.
55. Pauwels, K., Williams, T. L., Morris, K. L., Jonckheere, W., Vandersteen, A., Kelly, G., et al. (2012). Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease. J. Biol. Chem. 287, 5650-5660. doi: 10.1074/jbc.m111.264473.
56. Perez, M., Santa-Maria, I., Gomez de Barreda, E., Zhu, X., Cuadros, R., Cabrero, J. R., et al. (2009). Tau-an inhibitor of deacetylase HDAC6 function. J. Neurochem. 109, 1756-1766. doi: 10.1111/j.1471-4159.2009.06102.x.
57. Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., Santa Cruz, K., et al. (2005). Age-dependent neurofibrillary tangle formation, neuron loss and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 25, 10637-10647. doi: 10.1523/jneurosci.3279-05.2005.
58. R Development Core Team. (2014). R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing. Available online at: http://www.r-project.org.
59. Rebola, N., Pinheiro, P. C., Oliveira, C. R., Malva, J. O., and Cunha, R. A. (2003). Subcellular localization of adenosine A(1) receptors in nerve terminals and synapses of the rat hippocampus. Brain Res. 987, 49-58. doi: 10.1016/s0006-8993(03)03247-5.
60. Reddy, P. H., Mani, G., Park, B. S., Jacques, J., Murdoch, G., Whetsell, W. Jr., et al. (2005). Differential loss of synaptic proteins in Alzheimer’s disease: implications for synaptic dysfunction. J. Alzheimers Dis. 7, 103-117.
61. Rinne, J. O., Rummukainen, J., Paljärvi, L., Säkö, E., Mölsä, P., and Rinne, U. K. (1989). Neuronal loss in the substantia nigra in patients with Alzheimer’s disease and Parkinson’s disease in relation to extrapyramidal symptoms and dementia. Prog. Clin. Biol. Res. 317, 325-332.
62. Rodrigues, D. I., Gutierres, J., Pliássova, A., Oliveira, C. R., Cunha, R. A., and Agostinho, P. (2014). Synaptic and sub-synaptic localization of amyloid-β protein precursor in the rat hippocampus. J. Alzheimers Dis. 40, 981-992. doi: 10.3233/JAD-132030.
63. Sahara, N., Murayama, M., Higuchi, M., Suhara, T., and Takashima, A. (2014). Biochemical distribution of tau protein in synaptosomal fraction of transgenic mice expressing human P301L tau. Front. Neurol. 5:26. doi: 10.3389/fneur.2014.00026.
64. Samuel, W., Masliah, E., Hill, L. R., Butters, N., and Terry, R. (1994). Hippocampal connectivity and Alzheimer’s dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology 44, 2081-2088. doi: 10.1212/wnl.44.11.2081.
65. Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., and Mufson, E. J. (2007). Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68, 1501-1508. doi: 10.1212/01.wnl.0000260698.46517.8f.
66. Serrano-Pozo, A., Frosch, M. P., Masliah, E., and Hyman, B. T. (2011). Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1:a006189. doi: 10.1101/cshperspect.a006189.
67. Sze, C. I., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., and Martin, L. J. (2000). Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer’s disease brains. J. Neurol. Sci. 175, 81-90. doi: 10.1016/s0022-510x(00)00285-9.
68. Tai, H. C., Serrano-Pozo, A., Hashimoto, T., Frosch, M. P., Spires-Jones, T. L., and Hyman, B. T. (2012). The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am. J. Pathol. 181, 1426-1435. doi: 10.1016/j.ajpath.2012.06.033.
69. Takemura, R., Okabe, S., Umeyama, T., Kanai, Y., Cowan, N. J., and Hirokawa, N. (1992). Increased microtubule stability and alpha tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau. J. Cell Sci. 103, 953-964.
70. Tannenberg, R. K., Scott, H. L., Tannenberg, A. E., and Dodd, P. R. (2006). Selective loss of synaptic proteins in Alzheimer’s disease: evidence for an increased severity with APOE varepsilon4. Neurochem. Int. 49, 631-639. doi: 10.1016/j.neuint.2006.05.004.
71. Tao, F., Tao, Y. X., Mao, P., and Johns, R. A. (2003). Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in rats. Neuroscience 117, 731-739. doi: 10.1016/s0306-4522(02)00801-1.
72. Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., et al. (1991). Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580. doi: 10.1002/ana.410300410.
73. Vechterova, L., Kontsekova, E., Zilka, N., Ferencik, M., Ravid, R., and Novak, M. (2003). DC11: a novel monoclonal antibody revealing Alzheimer’s disease-specific tau epitope. Neuroreport 14, 87-91. doi: 10.1097/00001756-200301200-00017.
74. Verhey, K. J., and Gaertig, J. (2007). The tubulin code. Cell Cycle 6, 2152-2160. doi: 10.4161/cc.6.17.4633.
75. Wakabayashi, K., Honer, W. G., and Masliah, E. (1994). Synapse alterations in the hippocampal-entorhinal formation in Alzheimer’s disease with and without Lewy body disease. Brain Res. 667, 24-32. doi: 10.1016/0006-8993(94)91709-4.
76. Webster, D. R., Gundersen, G. G., Bulinski, J. C., and Borisy, G. G. (1987). Differential turnover of tyrosinated and detyrosinated microtubules. Proc. Natl. Acad. Sci. U S A 84, 9040-9044. doi: 10.1073/pnas.84.24.9040.
77. West, M. J., Coleman, P. D., Flood, D. G., and Troncoso, J. C. (1994). Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer’s disease. Lancet 344, 769-772. doi: 10.1016/s0140-6736(94)92338-8.
78. Willard, M., and Simon, C. (1983). Modulation of neurofilament axonal transport during the development of rabbit retinal ganglion cells. Cell 35, 551-559. doi: 10.1016/0092-8674(83)90189-7.
79. Wischik, C. M., Novak, M., Edwards, P. C., Klug, A., Tichelaar, W., and Crowther, R. A. (1988). Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U S A 85, 4884-4888. doi: 10.1073/pnas.85.13.4884.
80. Wu, J., Anwyl, R., and Rowan, M. J. (1995). beta-Amyloid-(1-40) increases long- term potentiation in rat hippocampus in vitro. Eur. J. Pharmacol. 284, R1-R3. doi: 10.1016/0014-2999(95)00539-w.
81. Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I. S., Duong, D. M., et al. (2014). Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease. Nat. Med. 20, 1254-1262. doi: 10.1038/nm.3700.
82. Zhou, L., Martinez, S. J., Haber, M., Jones, E. V., Bouvier, D., Doucet, G., et al. (2007). EphA4 signaling regulates phospholipase Cgamma1 activation, cofilin membrane association and dendritic spine morphology. J. Neurosci. 27, 5127-5138. doi: 10.1523/jneurosci.1170-07.2007.
83. Zilka, N., Filipcik, P., Koson, P., Fialova, L., Skrabana, R., Zilkova, M., et al. (2006). Truncated tau from sporadic Alzheimer’s disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett. 580, 3582-3588. doi: 10.1016/j.febslet.2006.05.029.